1. Home
  2. OXM vs RLMD Comparison

OXM vs RLMD Comparison

Compare OXM & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxford Industries Inc.

OXM

Oxford Industries Inc.

HOLD

Current Price

$26.34

Market Cap

543.0M

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$3.78

Market Cap

461.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXM
RLMD
Founded
1942
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
543.0M
461.9M
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
OXM
RLMD
Price
$26.34
$3.78
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$38.00
$12.40
AVG Volume (30 Days)
481.0K
1.1M
Earning Date
06-10-2026
05-08-2026
Dividend Yield
6.80%
N/A
EPS Growth
N/A
45.28
EPS
4.25
N/A
Revenue
$1,477,834,000.00
$13,070.00
Revenue This Year
$2.85
N/A
Revenue Next Year
$2.63
N/A
P/E Ratio
$6.61
N/A
Revenue Growth
N/A
154.83
52 Week Low
$27.85
$1.53
52 Week High
$49.58
$8.00

Technical Indicators

Market Signals
Indicator
OXM
RLMD
Relative Strength Index (RSI) 24.33 40.88
Support Level N/A $3.99
Resistance Level $42.57 $4.51
Average True Range (ATR) 1.41 0.20
MACD -0.39 0.03
Stochastic Oscillator 0.00 34.62

Price Performance

Historical Comparison
OXM
RLMD

About OXM Oxford Industries Inc.

Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company's business is organized as: Tommy Bahama, Lilly Pulitzer, Johnny Was and Emerging Brands reportable segments. Geographically, the company operates in United States as well as Internationally.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: